New hope for better sleep after gynecologic cancer: behavioral interventions show promise

NCT ID NCT05044975

Completed Symptom relief Sponsor: University of Arizona Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested three behavioral approaches—sleep restriction, stimulus control, and systematic light exposure—to help gynecologic cancer survivors who have trouble sleeping. 78 participants completed the program, and researchers measured changes in sleep quality and daytime impairment. The goal is to find safe, non-drug ways to improve sleep and quality of life for cancer survivors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral interventions (sleep restriction, stimulus control, systematic light exposure)
What this could lead to: If successful, this could point toward effective non-drug ways to help gynecologic cancer survivors get better sleep and feel more rested.
What could go wrong: This is a small, completed study (78 participants) without a control group, so results may not apply to everyone. Behavioral changes can be hard to maintain long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GYNECOLOGIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

female reproductive organ cancer Parasomnias sleep disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GYNECOLOGIC CANCER SLEEP DISTURBANCE

Contacts and locations

Locations

Northwestern University Feinberg School of Medicine

Chicago, Illinois, 60611, United States
University of Arizona College of Nursing

Tucson, Arizona, 85721, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.